Share Price and Basic Stock Data
Last Updated: November 8, 2025, 4:32 am
| PEG Ratio | 1.38 |
|---|
Analyst Insight & Comprehensive Analysis
Business Overview and Revenue Trends
Aarti Surfactants Ltd operates within the specialty chemicals sector, primarily engaged in manufacturing surfactants. The company reported a market capitalization of ₹392 Cr, with its stock price standing at ₹467. The revenue trajectory reveals a consistent growth pattern; sales rose from ₹576 Cr in FY 2022 to ₹601 Cr in FY 2023, followed by a marginal decline to ₹590 Cr in FY 2024. However, FY 2025 shows a rebound with sales reported at ₹659 Cr, and a trailing twelve months (TTM) revenue of ₹732 Cr. Quarterly sales figures further illustrate this trend, with a peak sales figure of ₹215.90 Cr in June 2025. The operating profit margin (OPM) fluctuated, recording a high of 11.30% in September 2023, but ultimately stood at 5.39% in June 2025. The company’s ability to navigate market fluctuations and maintain a robust revenue stream is commendable, especially given the competitive landscape of the specialty chemicals industry.
Profitability and Efficiency Metrics
Aarti Surfactants’ profitability metrics reflect a mixed performance. The net profit for FY 2025 stood at ₹15 Cr, which is a decline from ₹21 Cr in FY 2024, indicating challenges in maintaining profit levels. The net profit margin was reported at 2.20% for FY 2025, a decrease from 3.61% in FY 2024. The operating profit for the same period was ₹42 Cr, with an OPM of 6.88%, suggesting operational challenges. The interest coverage ratio (ICR) was reported at 3.93x, indicating a healthy capacity to cover interest expenses, although the return on equity (ROE) was relatively low at 5.14%. The company’s cash conversion cycle (CCC) stood at 71 days, reflecting a moderate efficiency in managing cash flow. These figures indicate that while Aarti Surfactants is generating revenue, it faces challenges in translating that into sustainable profitability, highlighting the need for operational improvements.
Balance Sheet Strength and Financial Ratios
Aarti Surfactants’ balance sheet reveals a stable financial position, with total borrowings reported at ₹110 Cr against reserves of ₹224 Cr. The debt-to-equity ratio stood at 0.37, indicating a conservative approach to leveraging, which is favorable for long-term stability. The company recorded a current ratio of 1.35, suggesting adequate liquidity to meet short-term obligations, while the quick ratio was lower at 0.63, indicating potential liquidity constraints when excluding inventory. The price-to-book value (P/BV) ratio was reported at 1.46x, which is relatively low compared to typical sector norms, suggesting that the stock may be undervalued relative to its book value. Furthermore, the return on capital employed (ROCE) stood at 8.50%, which is modest and indicates that capital is not being utilized to its full potential. Overall, while the balance sheet is solid, there are areas that require attention for improved financial efficiency.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Aarti Surfactants reflects a stable distribution. Promoters hold 49.92% of the shares, indicating a strong commitment to the company. The public holds 49.27%, while foreign institutional investors (FIIs) have a negligible stake of 0.00%, and domestic institutional investors (DIIs) hold 0.80%. The number of shareholders has declined from 41,465 in September 2022 to 37,835 by June 2025, suggesting a potential reduction in retail interest. However, the consistent promoter holding could instill confidence among investors regarding the company’s strategic direction. The low FIIs participation may indicate a perception of risk or a lack of awareness of Aarti Surfactants’ growth potential among foreign investors. Overall, the stable promoter shareholding coupled with a high public stake suggests a balanced approach to governance and investor relations.
Outlook, Risks, and Final Insight
Looking ahead, Aarti Surfactants faces a mixed outlook influenced by both opportunities and risks. On the one hand, the rebound in sales and stable market capitalization position the company well for future growth. However, the declining profit margins and fluctuating operating profits present significant operational challenges. The company must focus on improving its cost structure and enhancing operational efficiencies to sustain profitability. Additionally, the lack of institutional investment may hinder broader market confidence. Risks include potential volatility in raw material prices, which can impact margins, and competitive pressures from larger players in the specialty chemicals sector. In conclusion, while Aarti Surfactants has shown resilience in revenue generation, strategic initiatives aimed at enhancing profitability and investor confidence will be crucial for its long-term success.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Aarti Surfactants Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 451 Cr. | 49.1 | 86.7/42.6 | 27.5 | 20.0 | 0.81 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 37.6 Cr. | 76.6 | 103/56.0 | 16.8 | 87.4 | 1.30 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 45.1 Cr. | 663 | 1,140/0.00 | 20.8 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,658 Cr. | 80.7 | 114/78.0 | 24.2 | 22.0 | 0.62 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 730 Cr. | 293 | 453/241 | 26.2 | 91.1 | 0.85 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,640.28 Cr | 720.76 | 46.00 | 180.15 | 0.41% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 158.13 | 151.77 | 133.55 | 157.84 | 148.70 | 143.86 | 138.75 | 158.55 | 143.41 | 150.84 | 162.78 | 202.05 | 215.90 |
| Expenses | 146.63 | 143.00 | 119.98 | 143.94 | 133.90 | 127.60 | 122.02 | 144.21 | 133.79 | 147.12 | 153.89 | 182.36 | 204.27 |
| Operating Profit | 11.50 | 8.77 | 13.57 | 13.90 | 14.80 | 16.26 | 16.73 | 14.34 | 9.62 | 3.72 | 8.89 | 19.69 | 11.63 |
| OPM % | 7.27% | 5.78% | 10.16% | 8.81% | 9.95% | 11.30% | 12.06% | 9.04% | 6.71% | 2.47% | 5.46% | 9.75% | 5.39% |
| Other Income | 0.10 | 0.09 | 0.06 | 0.09 | 0.03 | 0.03 | 0.03 | 0.05 | 0.49 | 6.21 | -0.16 | 1.14 | 0.04 |
| Interest | 2.98 | 3.74 | 4.16 | 3.91 | 3.32 | 3.66 | 3.65 | 3.41 | 2.57 | 2.60 | 3.12 | 3.26 | 3.28 |
| Depreciation | 3.49 | 4.06 | 4.01 | 3.93 | 3.95 | 3.85 | 4.02 | 4.21 | 4.23 | 4.31 | 4.40 | 4.41 | 4.35 |
| Profit before tax | 5.13 | 1.06 | 5.46 | 6.15 | 7.56 | 8.78 | 9.09 | 6.77 | 3.31 | 3.02 | 1.21 | 13.16 | 4.04 |
| Tax % | 27.68% | 69.81% | 27.11% | 23.90% | 30.56% | 45.90% | 26.40% | 31.17% | 32.93% | 40.07% | 33.88% | 26.22% | 27.23% |
| Net Profit | 3.71 | 0.32 | 3.98 | 4.69 | 5.25 | 4.74 | 6.68 | 4.65 | 2.22 | 1.81 | 0.80 | 9.72 | 2.94 |
| EPS in Rs | 4.36 | 0.38 | 4.68 | 5.52 | 6.18 | 5.58 | 7.86 | 5.50 | 2.62 | 2.14 | 0.95 | 11.49 | 3.48 |
Last Updated: August 20, 2025, 12:50 am
Below is a detailed analysis of the quarterly data for Aarti Surfactants Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 215.90 Cr.. The value appears strong and on an upward trend. It has increased from 202.05 Cr. (Mar 2025) to 215.90 Cr., marking an increase of 13.85 Cr..
- For Expenses, as of Jun 2025, the value is 204.27 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 182.36 Cr. (Mar 2025) to 204.27 Cr., marking an increase of 21.91 Cr..
- For Operating Profit, as of Jun 2025, the value is 11.63 Cr.. The value appears to be declining and may need further review. It has decreased from 19.69 Cr. (Mar 2025) to 11.63 Cr., marking a decrease of 8.06 Cr..
- For OPM %, as of Jun 2025, the value is 5.39%. The value appears to be declining and may need further review. It has decreased from 9.75% (Mar 2025) to 5.39%, marking a decrease of 4.36%.
- For Other Income, as of Jun 2025, the value is 0.04 Cr.. The value appears to be declining and may need further review. It has decreased from 1.14 Cr. (Mar 2025) to 0.04 Cr., marking a decrease of 1.10 Cr..
- For Interest, as of Jun 2025, the value is 3.28 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.26 Cr. (Mar 2025) to 3.28 Cr., marking an increase of 0.02 Cr..
- For Depreciation, as of Jun 2025, the value is 4.35 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.41 Cr. (Mar 2025) to 4.35 Cr., marking a decrease of 0.06 Cr..
- For Profit before tax, as of Jun 2025, the value is 4.04 Cr.. The value appears to be declining and may need further review. It has decreased from 13.16 Cr. (Mar 2025) to 4.04 Cr., marking a decrease of 9.12 Cr..
- For Tax %, as of Jun 2025, the value is 27.23%. The value appears to be increasing, which may not be favorable. It has increased from 26.22% (Mar 2025) to 27.23%, marking an increase of 1.01%.
- For Net Profit, as of Jun 2025, the value is 2.94 Cr.. The value appears to be declining and may need further review. It has decreased from 9.72 Cr. (Mar 2025) to 2.94 Cr., marking a decrease of 6.78 Cr..
- For EPS in Rs, as of Jun 2025, the value is 3.48. The value appears to be declining and may need further review. It has decreased from 11.49 (Mar 2025) to 3.48, marking a decrease of 8.01.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:05 am
| Metric | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 326 | 466 | 576 | 601 | 590 | 659 | 732 |
| Expenses | 302 | 420 | 543 | 554 | 528 | 617 | 688 |
| Operating Profit | 24 | 46 | 32 | 48 | 62 | 42 | 44 |
| OPM % | 7% | 10% | 6% | 8% | 11% | 6% | 6% |
| Other Income | 0 | 0 | 0 | 0 | 0 | 8 | 7 |
| Interest | 10 | 10 | 11 | 15 | 14 | 12 | 12 |
| Depreciation | 11 | 12 | 12 | 15 | 16 | 17 | 17 |
| Profit before tax | 3 | 23 | 9 | 18 | 32 | 21 | 21 |
| Tax % | 29% | 6% | 41% | 29% | 34% | 30% | |
| Net Profit | 2 | 22 | 5 | 13 | 21 | 15 | 15 |
| EPS in Rs | 2.46 | 25.45 | 6.46 | 14.94 | 25.22 | 17.19 | 18.06 |
| Dividend Payout % | 0% | 11% | 0% | 0% | 0% | 6% |
YoY Net Profit Growth
| Year | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 1000.00% | -77.27% | 160.00% | 61.54% | -28.57% |
| Change in YoY Net Profit Growth (%) | 0.00% | -1077.27% | 237.27% | -98.46% | -90.11% |
Aarti Surfactants Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 5 years from 2020-2021 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 15% |
| 3 Years: | 5% |
| TTM: | 25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 41% |
| 3 Years: | 28% |
| TTM: | -31% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | -2% |
| 3 Years: | -17% |
| 1 Year: | -27% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 9% |
| 3 Years: | 8% |
| Last Year: | 5% |
Last Updated: September 5, 2025, 2:01 pm
Balance Sheet
Last Updated: September 10, 2025, 2:52 pm
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Equity Capital | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves | 103 | 125 | 128 | 160 | 210 | 224 |
| Borrowings | 109 | 152 | 162 | 149 | 99 | 110 |
| Other Liabilities | 42 | 102 | 105 | 86 | 105 | 134 |
| Total Liabilities | 262 | 387 | 402 | 404 | 422 | 477 |
| Fixed Assets | 151 | 187 | 173 | 207 | 208 | 204 |
| CWIP | 14 | 20 | 52 | 8 | 8 | 15 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 97 | 180 | 178 | 188 | 206 | 259 |
| Total Assets | 262 | 387 | 402 | 404 | 422 | 477 |
Below is a detailed analysis of the balance sheet data for Aarti Surfactants Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 8.00 Cr..
- For Reserves, as of Mar 2025, the value is 224.00 Cr.. The value appears strong and on an upward trend. It has increased from 210.00 Cr. (Mar 2024) to 224.00 Cr., marking an increase of 14.00 Cr..
- For Borrowings, as of Mar 2025, the value is 110.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 99.00 Cr. (Mar 2024) to 110.00 Cr., marking an increase of 11.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 134.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 105.00 Cr. (Mar 2024) to 134.00 Cr., marking an increase of 29.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 477.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 422.00 Cr. (Mar 2024) to 477.00 Cr., marking an increase of 55.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 204.00 Cr.. The value appears to be declining and may need further review. It has decreased from 208.00 Cr. (Mar 2024) to 204.00 Cr., marking a decrease of 4.00 Cr..
- For CWIP, as of Mar 2025, the value is 15.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2024) to 15.00 Cr., marking an increase of 7.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 259.00 Cr.. The value appears strong and on an upward trend. It has increased from 206.00 Cr. (Mar 2024) to 259.00 Cr., marking an increase of 53.00 Cr..
- For Total Assets, as of Mar 2025, the value is 477.00 Cr.. The value appears strong and on an upward trend. It has increased from 422.00 Cr. (Mar 2024) to 477.00 Cr., marking an increase of 55.00 Cr..
Notably, the Reserves (224.00 Cr.) exceed the Borrowings (110.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Free Cash Flow | -85.00 | -106.00 | -130.00 | -101.00 | -37.00 | -68.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|
| Debtor Days | 20 | 43 | 35 | 40 | 43 | 42 |
| Inventory Days | 83 | 76 | 60 | 60 | 81 | 92 |
| Days Payable | 28 | 81 | 56 | 44 | 55 | 63 |
| Cash Conversion Cycle | 75 | 38 | 38 | 55 | 69 | 71 |
| Working Capital Days | -1 | 3 | 16 | 20 | 40 | 36 |
| ROCE % | 13% | 7% | 11% | 15% | 8% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 17.20 | 26.63 | 16.64 | 7.25 | 28.53 |
| Diluted EPS (Rs.) | 17.19 | 25.16 | 16.47 | 7.25 | 28.53 |
| Cash EPS (Rs.) | 37.67 | 44.13 | 35.50 | 23.65 | 44.62 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 274.78 | 257.64 | 211.58 | 179.20 | 174.90 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 274.78 | 257.64 | 211.58 | 179.20 | 174.90 |
| Revenue From Operations / Share (Rs.) | 778.53 | 696.75 | 757.16 | 758.81 | 614.11 |
| PBDIT / Share (Rs.) | 53.62 | 73.54 | 60.53 | 42.76 | 60.08 |
| PBIT / Share (Rs.) | 33.13 | 54.60 | 41.03 | 26.35 | 43.98 |
| PBT / Share (Rs.) | 24.45 | 38.02 | 22.41 | 12.29 | 30.21 |
| Net Profit / Share (Rs.) | 17.18 | 25.19 | 16.00 | 7.24 | 28.52 |
| NP After MI And SOA / Share (Rs.) | 17.18 | 25.19 | 16.00 | 7.24 | 28.52 |
| PBDIT Margin (%) | 6.88 | 10.55 | 7.99 | 5.63 | 9.78 |
| PBIT Margin (%) | 4.25 | 7.83 | 5.41 | 3.47 | 7.16 |
| PBT Margin (%) | 3.14 | 5.45 | 2.96 | 1.61 | 4.91 |
| Net Profit Margin (%) | 2.20 | 3.61 | 2.11 | 0.95 | 4.64 |
| NP After MI And SOA Margin (%) | 2.20 | 3.61 | 2.11 | 0.95 | 4.64 |
| Return on Networth / Equity (%) | 6.25 | 9.77 | 7.56 | 4.04 | 16.30 |
| Return on Capital Employeed (%) | 9.64 | 15.77 | 12.73 | 7.88 | 15.02 |
| Return On Assets (%) | 3.04 | 5.05 | 3.15 | 1.36 | 5.59 |
| Long Term Debt / Equity (X) | 0.02 | 0.12 | 0.31 | 0.62 | 0.46 |
| Total Debt / Equity (X) | 0.37 | 0.34 | 0.76 | 1.04 | 0.99 |
| Asset Turnover Ratio (%) | 1.47 | 1.43 | 1.49 | 1.46 | 1.44 |
| Current Ratio (X) | 1.35 | 1.54 | 1.26 | 1.17 | 1.07 |
| Quick Ratio (X) | 0.63 | 0.77 | 0.73 | 0.67 | 0.62 |
| Inventory Turnover Ratio (X) | 5.64 | 5.05 | 6.15 | 6.25 | 5.49 |
| Interest Coverage Ratio (X) | 3.93 | 4.44 | 3.25 | 3.04 | 4.36 |
| Interest Coverage Ratio (Post Tax) (X) | 1.90 | 2.52 | 1.86 | 1.52 | 3.07 |
| Enterprise Value (Cr.) | 446.96 | 559.15 | 501.39 | 729.76 | 852.31 |
| EV / Net Operating Revenue (X) | 0.67 | 0.94 | 0.83 | 1.27 | 1.83 |
| EV / EBITDA (X) | 9.85 | 8.98 | 10.43 | 22.50 | 18.71 |
| MarketCap / Net Operating Revenue (X) | 0.51 | 0.79 | 0.59 | 0.98 | 1.52 |
| Price / BV (X) | 1.46 | 2.15 | 2.14 | 4.19 | 5.33 |
| Price / Net Operating Revenue (X) | 0.51 | 0.79 | 0.59 | 0.98 | 1.52 |
| EarningsYield | 0.04 | 0.04 | 0.03 | 0.01 | 0.03 |
After reviewing the key financial ratios for Aarti Surfactants Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 17.20. This value is within the healthy range. It has decreased from 26.63 (Mar 24) to 17.20, marking a decrease of 9.43.
- For Diluted EPS (Rs.), as of Mar 25, the value is 17.19. This value is within the healthy range. It has decreased from 25.16 (Mar 24) to 17.19, marking a decrease of 7.97.
- For Cash EPS (Rs.), as of Mar 25, the value is 37.67. This value is within the healthy range. It has decreased from 44.13 (Mar 24) to 37.67, marking a decrease of 6.46.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 274.78. It has increased from 257.64 (Mar 24) to 274.78, marking an increase of 17.14.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 274.78. It has increased from 257.64 (Mar 24) to 274.78, marking an increase of 17.14.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 778.53. It has increased from 696.75 (Mar 24) to 778.53, marking an increase of 81.78.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 53.62. This value is within the healthy range. It has decreased from 73.54 (Mar 24) to 53.62, marking a decrease of 19.92.
- For PBIT / Share (Rs.), as of Mar 25, the value is 33.13. This value is within the healthy range. It has decreased from 54.60 (Mar 24) to 33.13, marking a decrease of 21.47.
- For PBT / Share (Rs.), as of Mar 25, the value is 24.45. This value is within the healthy range. It has decreased from 38.02 (Mar 24) to 24.45, marking a decrease of 13.57.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 17.18. This value is within the healthy range. It has decreased from 25.19 (Mar 24) to 17.18, marking a decrease of 8.01.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 17.18. This value is within the healthy range. It has decreased from 25.19 (Mar 24) to 17.18, marking a decrease of 8.01.
- For PBDIT Margin (%), as of Mar 25, the value is 6.88. This value is below the healthy minimum of 10. It has decreased from 10.55 (Mar 24) to 6.88, marking a decrease of 3.67.
- For PBIT Margin (%), as of Mar 25, the value is 4.25. This value is below the healthy minimum of 10. It has decreased from 7.83 (Mar 24) to 4.25, marking a decrease of 3.58.
- For PBT Margin (%), as of Mar 25, the value is 3.14. This value is below the healthy minimum of 10. It has decreased from 5.45 (Mar 24) to 3.14, marking a decrease of 2.31.
- For Net Profit Margin (%), as of Mar 25, the value is 2.20. This value is below the healthy minimum of 5. It has decreased from 3.61 (Mar 24) to 2.20, marking a decrease of 1.41.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 2.20. This value is below the healthy minimum of 8. It has decreased from 3.61 (Mar 24) to 2.20, marking a decrease of 1.41.
- For Return on Networth / Equity (%), as of Mar 25, the value is 6.25. This value is below the healthy minimum of 15. It has decreased from 9.77 (Mar 24) to 6.25, marking a decrease of 3.52.
- For Return on Capital Employeed (%), as of Mar 25, the value is 9.64. This value is below the healthy minimum of 10. It has decreased from 15.77 (Mar 24) to 9.64, marking a decrease of 6.13.
- For Return On Assets (%), as of Mar 25, the value is 3.04. This value is below the healthy minimum of 5. It has decreased from 5.05 (Mar 24) to 3.04, marking a decrease of 2.01.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has decreased from 0.12 (Mar 24) to 0.02, marking a decrease of 0.10.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.37. This value is within the healthy range. It has increased from 0.34 (Mar 24) to 0.37, marking an increase of 0.03.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.47. It has increased from 1.43 (Mar 24) to 1.47, marking an increase of 0.04.
- For Current Ratio (X), as of Mar 25, the value is 1.35. This value is below the healthy minimum of 1.5. It has decreased from 1.54 (Mar 24) to 1.35, marking a decrease of 0.19.
- For Quick Ratio (X), as of Mar 25, the value is 0.63. This value is below the healthy minimum of 1. It has decreased from 0.77 (Mar 24) to 0.63, marking a decrease of 0.14.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.64. This value is within the healthy range. It has increased from 5.05 (Mar 24) to 5.64, marking an increase of 0.59.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 3.93. This value is within the healthy range. It has decreased from 4.44 (Mar 24) to 3.93, marking a decrease of 0.51.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.90. This value is below the healthy minimum of 3. It has decreased from 2.52 (Mar 24) to 1.90, marking a decrease of 0.62.
- For Enterprise Value (Cr.), as of Mar 25, the value is 446.96. It has decreased from 559.15 (Mar 24) to 446.96, marking a decrease of 112.19.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.67. This value is below the healthy minimum of 1. It has decreased from 0.94 (Mar 24) to 0.67, marking a decrease of 0.27.
- For EV / EBITDA (X), as of Mar 25, the value is 9.85. This value is within the healthy range. It has increased from 8.98 (Mar 24) to 9.85, marking an increase of 0.87.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.51. This value is below the healthy minimum of 1. It has decreased from 0.79 (Mar 24) to 0.51, marking a decrease of 0.28.
- For Price / BV (X), as of Mar 25, the value is 1.46. This value is within the healthy range. It has decreased from 2.15 (Mar 24) to 1.46, marking a decrease of 0.69.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.51. This value is below the healthy minimum of 1. It has decreased from 0.79 (Mar 24) to 0.51, marking a decrease of 0.28.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Aarti Surfactants Ltd:
- Net Profit Margin: 2.2%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.64% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 6.25% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.9
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.63
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 31.6 (Industry average Stock P/E: 46)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.37
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.2%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Plot Nos. 57, 58, 60 to 64, 62A, S-3/1, Dhar District Madhya Pradesh 454775 | investors@aarti-surfactants.com http://www.aarti-surfactants.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Mulesh Manilal Savla | Chairman(NonExe.&Ind.Director) |
| Mr. Nikhil Parimal Desai | Managing Director & CEO |
| Mr. Santosh Madhaorao Kakade | Executive Director |
| Mr. Chandrakant Vallabhaji Gogri | Non Exe.Non Ind.Director |
| Mr. Dattatray Sidram Galpalli | Non Exe.Non Ind.Director |
| Mrs. Misha Bharat Gala | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Aarti Surfactants Ltd?
Aarti Surfactants Ltd's intrinsic value (as of 08 November 2025) is 358.08 which is 23.81% lower the current market price of 470.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 397 Cr. market cap, FY2025-2026 high/low of 749/388, reserves of ₹224 Cr, and liabilities of 477 Cr.
What is the Market Cap of Aarti Surfactants Ltd?
The Market Cap of Aarti Surfactants Ltd is 397 Cr..
What is the current Stock Price of Aarti Surfactants Ltd as on 08 November 2025?
The current stock price of Aarti Surfactants Ltd as on 08 November 2025 is 470.
What is the High / Low of Aarti Surfactants Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Aarti Surfactants Ltd stocks is 749/388.
What is the Stock P/E of Aarti Surfactants Ltd?
The Stock P/E of Aarti Surfactants Ltd is 31.6.
What is the Book Value of Aarti Surfactants Ltd?
The Book Value of Aarti Surfactants Ltd is 275.
What is the Dividend Yield of Aarti Surfactants Ltd?
The Dividend Yield of Aarti Surfactants Ltd is 0.21 %.
What is the ROCE of Aarti Surfactants Ltd?
The ROCE of Aarti Surfactants Ltd is 8.50 %.
What is the ROE of Aarti Surfactants Ltd?
The ROE of Aarti Surfactants Ltd is 5.14 %.
What is the Face Value of Aarti Surfactants Ltd?
The Face Value of Aarti Surfactants Ltd is 10.0.